✦ LIBER ✦

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial

✍ Scribed by Zefeng Zhang; Jovonne K. Foster; Paul Kolm; Claudine T. Jurkovitz; Karen M. Parker; Nancy V. Murrah; Grant T. Anderson; John S. Douglas Jr.; William S. Weintraub

Book ID: 116190560
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 250 KB
Volume: 152
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2006.03.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Multicenter

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 653 KB